期刊文献+

沐舒坦针剂治疗兔创伤性急性肺损伤的实验研究 被引量:15

Study of mucosolvan treatment of traumatic ALI in rabbits
下载PDF
导出
摘要 目的 在兔创伤性肺损伤早期应用盐酸氨溴素 (沐舒坦 ) ,观察其对兔创伤性急性肺损伤的疗效并探讨其作用机制。方法 将实验动物 (新西兰兔 )随机分为 3组 :Ⅰ组 :对照组 (n =12 ) ;Ⅱ组 :常规剂量沐舒坦治疗组 ,静脉注射沐舒坦 5mg/kg(n =12 ) ;Ⅲ组 :大剂量沐舒坦组 ,静脉注射沐舒坦 15mg/kg (n=12 )。 3组动物均采用自行研制的BIM Ⅵ型生物撞击机撞击动物右侧胸壁致伤。分别于伤前和伤后 1、3、7小时记录动物的心率、呼吸频率的变化 ,并通过静脉插管抽血以测定血气、肿瘤坏死因子 -α(TNF α)、白细胞介素 - 1(IL 1)、IL 6、IL 8等指标 ,并进行肺组织的病理学检查。结果 实验动物肺损伤发生率达 10 0 %(36 / 36 )。对照组动物 (Ⅰ组 )伤后PaO2 明显低于Ⅱ组和Ⅲ组 (P <0 .0 5 ) ,PaCO2 明显高于Ⅱ组和Ⅲ组 (P <0 .0 5 )。Ⅱ、Ⅲ组间PaO2 、PaCO2 比较无显著性差异。Ⅱ、Ⅲ组外周血促炎因子TNF α及IL 1、IL 6、IL 8含量显著低于对照组 (P <0 .0 5 ) ,Ⅲ组血浆炎性细胞因子水平低于Ⅱ组血浆炎性细胞因子水平 (P <0 .0 5 )。组织病理学检查 :Ⅱ、Ⅲ组动物肺组织水肿、灶性出血、肺不张等急性肺损伤的表现较Ⅰ组明显减轻 ,而Ⅲ组的上述急性肺损伤的表现相对Ⅱ组有所减轻。 Objective To investigate the effects of mucosolum on acute lung injury after trauma in rabbits and its mechanism.Methods Thirty-six rabbit were divided randomly into 3 groups.Group Ⅰ:control group,12 rabbits;Ⅱ:normal dosage mucosolvan group,12 rabbits;Ⅲ:large dosage mucosolvan group,12 rabbits.The model of thoraco-abdominal impact injury in rabbits was established with a steel ball falling down to the xiphoid process of animals.Mucosolvan was injected with a dose of 15 mg/kg.Preparation of the rabbits and the wounding methods were the same.ResultsThe morbidity of acute lung injury is 100%(36/36).In group Ⅰ,PaO 2 decreased sharply after trauma.In group Ⅱ and Ⅲ,the decrease of PaO 2 were less serious than that of group Ⅰ.The content of TNF-α,IL-1,IL-6 and IL-8 in group Ⅰ was more than those of group Ⅱ and Ⅲ(P<0.05).The content of TNF-α,IL-1,IL-6 and IL-8 in group Ⅲ was less than that of group Ⅱ(P<0.05).In group Ⅱ and Ⅲ,pathologic changes of ALI such as pulmonary edema,focal hemorrhage,atelectasis were less serious than that of group Ⅰ.In group Ⅲ,those changes were less serious than that of group Ⅱ.Conclusion Mucosolvan has definite treatment effects on traumatic ALI.
出处 《创伤外科杂志》 2005年第1期57-60,共4页 Journal of Traumatic Surgery
关键词 肺损伤 细胞因子 氧分压 沐舒坦 lung injury cytokine PaO 2 mucosolvan rabbit
  • 相关文献

参考文献6

二级参考文献13

  • 1[1]Gillissen A, Nowak D. Characterization of N-acetylcysteine and ambroxol in anti-oxidant therapy. Respir Med, 1998, 92:609-623. 被引量:1
  • 2[2]Teramoto S, Suzuki M, Ohga E, et al. Effects of ambroxol on spontaneous or stimulated generation of reactive oxygen species by bronchoalveolar lavage cells harvested from patients with or with-out chronic obstructive pulmonary diseases. Pharmacology,1999, 59:135-141. 被引量:1
  • 3[3]Gillissen A, Bartling A, Schoen S, et al. Antioxidant function of ambroxol in mononuclear and polymorphonuclear cells in vitro. Lung, 1997, 175:235-242. 被引量:1
  • 4[4]Park NH, Han ES, Lee CS, et al. The inhibitory effect of ambroxol on respiratory burst, de granulation and cytosolic Ca2+ change in degraded immunoglobulin G-activated neutrophils. Pharmacol Toxicol, 1999, 84: 81-87. 被引量:1
  • 5[5]Pfeifer S, Zissel G, Kienast K, et al. Reduction of cytokine release of blood and bronchoalveolar mononuclear cells by ambroxol. EurJ Med Res, 1997, 2:129-132. 被引量:1
  • 6[6]Stettner S, Ledwozyw A. The effect of Ambroxol on bleomycininduced changes in phospholipid composition of rat lung surfactant. Acta Physiol Hung, 1995, 83:181-187. 被引量:1
  • 7[7]Mira E, Benazzo M, De Paoli F, et al. Surfactants of the air-ways. Critical review and personal research. Acta Otorhinolaryngol Ital, 1997, 17(1 Suppl 56):3-16. 被引量:1
  • 8[8]Nemcekova E, Nosalova G, Franova S. Ambroxol and protective reflexes of the respiratory tract. Bratisl Lek Listy, 1998, 99:111-115. 被引量:1
  • 9[9]Tyrakowski T, Greczko Ⅰ, Sedlaczek A, et al. Electrophysiological investigation of the effects of ambroxol on the transepithelial Na + ion transport pathway in airways. Pol J Pharmacol,1998, 50:31-38. 被引量:1
  • 10[10]Tyrakowski T, Sedlaczek A, Greczko Ⅰ, et al. Ambroxol effect on transepithelial electrical potential difference of isolated tracheal wall. Pol J Pharmacol, 1997, 49:53-58. 被引量:1

共引文献408

同被引文献135

引证文献15

二级引证文献88

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部